Literature DB >> 20587861

Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy.

Robert Dennert1, Sebastiaan Velthuis, Dirk Westermann, Dirk Donker, Simon Schalla, Robert-Jan van Suylen, Stephane Heymans.   

Abstract

Fulminant myocarditis is a rare inflammatory heart disease affecting relatively young adults. We describe a case of a 27-year-old male with acute onset severe heart failure. A rapid and accurate diagnostic approach suggested parvovirus B19 as the most probable cause for this fulminant viral myocarditis. Initial haemodynamic support, intensive immunosuppressive and antiviral therapy resulted in a complete recovery within 2 weeks. This case demonstrates the importance of a detailed diagnosis, allowing better classification of the underlying pathology and subsequent targeted treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587861     DOI: 10.3851/IMP1563

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  6 in total

Review 1.  Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.

Authors:  Bernhard Maisch; Volker Ruppert; Sabine Pankuweit
Journal:  Curr Heart Fail Rep       Date:  2014-06

2.  Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support.

Authors:  Hiroshi Nakashima; Yasuhiro Umeyama; Kazutoshi Minami
Journal:  Am J Case Rep       Date:  2013-04-23

3.  Acute myocarditis mimicking ST-elevation myocardial infarction: A case report and review of the literature.

Authors:  Tao Zhang; Wei Miao; Shixuan Wang; Min Wei; Guohai Su; Zhenhua Li
Journal:  Exp Ther Med       Date:  2015-06-12       Impact factor: 2.447

4.  Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.

Authors:  Marion Dollat; Benjamin Chaigne; Grégoire Cormier; Nathalie Costedoat-Chalumeau; François Lifermann; Alban Deroux; Emilie Berthoux; Emmanuelle Dernis; Thomas Sené; Gilles Blaison; Olivier Lambotte; Benjamin Terrier; Jérémie Sellam; Luc De Saint-Martin; Laurent Chiche; Nicolas Dupin; Luc Mouthon
Journal:  BMC Infect Dis       Date:  2018-07-04       Impact factor: 3.090

5.  Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.

Authors:  Linda Rolf; Anne-Hilde Muris; Amandine Mathias; Renaud Du Pasquier; Inga Koneczny; Giulio Disanto; Jens Kuhle; Sreeram Ramagopalan; Jan Damoiseaux; Joost Smolders; Raymond Hupperts
Journal:  Mult Scler       Date:  2017-07-21       Impact factor: 6.312

Review 6.  Triggers of Inflammatory Heart Disease.

Authors:  Ninaad Lasrado; Bharathi Yalaka; Jay Reddy
Journal:  Front Cell Dev Biol       Date:  2020-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.